Thank you, Chair.
Thanks to all of you for coming today.
Dr. Edwards, before this, we were talking about genetic testing. We were speaking with another witness who has found that it is unlikely to find actual genotypical abnormalities when the embryopathy is due to thalidomide.
You've just said that if you had a given syndrome of abnormalities and all the criteria that Mr. Davies talked about, you would have probably a 95% probability that it was thalidomide. If you had someone in this group, and your genetic testing then showed no abnormalities, would that even further increase your likelihood that this is thalidomide and not a genetic cause?